KPV

Overview

KPV is a naturally occurring C-terminal tripeptide fragment of alpha-melanocyte-stimulating hormone (α-MSH). Despite its small size, KPV retains significant biological activity attributed to the parent hormone. It has been studied primarily for its anti-inflammatory properties in preclinical models, particularly in the context of gastrointestinal and dermatological research.

Research Summary

Research on KPV has focused on its anti-inflammatory properties in multiple preclinical models. Studies in cell culture systems have examined its effects on NF-κB signaling, pro-inflammatory cytokine production, and inflammatory cell activation. Animal studies have investigated its effects in models of colitis, dermatitis, and other inflammatory conditions. Research has also examined delivery methods including oral, topical, and nanoparticle-based administration. KPV retains the anti-inflammatory signaling of α-MSH while being metabolically simpler and more resistant to enzymatic degradation.

Proposed Mechanism of Action

KPV is understood to modulate inflammatory responses through direct interaction with NF-κB signaling pathways, inhibiting nuclear translocation and reducing transcription of pro-inflammatory genes. Research indicates it enters cells through PepT1 transporter-mediated uptake and may interact with melanocortin receptor pathways independently of classical MC1R binding.

Vendor Availability

Published Research References

References are provided for informational purposes. PeptiNox does not endorse or validate the conclusions of cited studies. All listed research pertains to preclinical or in vitro investigations unless otherwise noted.